|
MTHFD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.283400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.048800E-01 |
| Normal-vs-Stage2 |
1.733170E-01 |
| Normal-vs-Stage3 |
3.629600E-01 |
| Normal-vs-Stage4 |
6.735600E-01 |
| Stage1-vs-Stage2 |
1.579600E-02 |
| Stage1-vs-Stage3 |
7.073200E-01 |
| Stage1-vs-Stage4 |
8.936500E-02 |
| Stage2-vs-Stage3 |
2.892000E-02 |
| Stage2-vs-Stage4 |
3.401800E-01 |
| Stage3-vs-Stage4 |
2.286200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.131400E-01 |
| Normal-vs-AfricanAmerican |
4.262000E-01 |
| Normal-vs-Asian |
7.052600E-01 |
| Caucasian-vs-AfricanAmerican |
7.922800E-01 |
| Caucasian-vs-Asian |
8.371000E-01 |
| AfricanAmerican-vs-Asian |
7.128600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.015200E-01 |
| Normal-vs-Female |
6.115400E-01 |
| Male-vs-Female |
2.574400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.291400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.414400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.547200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.703400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.524600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.097900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.849800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.638400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.999400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.505800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.154200E-01 |
| Classical-VS-Follicular |
5.284800E-01 |
| Classical-VS-Other |
1.653570E-01 |
| Classical-VS-Normal |
4.425400E-01 |
| Tall-VS-Follicular |
5.815400E-01 |
| Tall-VS-Other |
7.470000E-02 |
| Tall-VS-Normal |
5.719200E-01 |
| Follicular-VS-Other |
2.504600E-01 |
| Follicular-VS-Normal |
9.539000E-01 |
| Other-VS-Normal |
7.593600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.841000E-01 |
| Normal-vs-N1 |
4.072300E-02 |
| N0-vs-N1 |
1.043010E-01 |
|
|
